Cargando…

The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil

BACKGROUND: The worldwide increase of diabetes, a long duration, slow progression disease, impacts health care costs. The aim of this study was to estimate, from the society’s perspective, the annual cost per patient with Type 2 Diabetes (T2DM) at a specialized, outpatient center in the city of São...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Natalie Botelho, Ferraz, Marcos Bosi, Chacra, Antonio Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232724/
https://www.ncbi.nlm.nih.gov/pubmed/25400703
http://dx.doi.org/10.1186/1758-5996-6-122
_version_ 1782344624698818560
author Borges, Natalie Botelho
Ferraz, Marcos Bosi
Chacra, Antonio Roberto
author_facet Borges, Natalie Botelho
Ferraz, Marcos Bosi
Chacra, Antonio Roberto
author_sort Borges, Natalie Botelho
collection PubMed
description BACKGROUND: The worldwide increase of diabetes, a long duration, slow progression disease, impacts health care costs. The aim of this study was to estimate, from the society’s perspective, the annual cost per patient with Type 2 Diabetes (T2DM) at a specialized, outpatient center in the city of São Paulo, capital of São Paulo state, Brazil. METHODS: Data from 209 patients were collected during the years 2009 and 2010 in a São Paulo diabetes care center which is part of the tertiary sector of SUS, Brazil’s National Health Care System. Data were collected by means of interviews and reviews of medical charts, and the quality of life was appraised using the SF36-v2 questionnaire. Direct medical costs were divided in five categories: 1) medication; 2) laboratory tests; 3) hospitalizations and procedures; 4) reactive strips for capillary blood glucose monitoring; and 5) medical consultations. Direct non-medical costs referred to transportation of patient and companion for treatment. Indirect costs included early retirements, sick leave and absenteeism in the workplace. Statistical analysis of the data was performed by the SPSS software, version 17.0. RESULTS: Our sample comprised 122 women (58%) and 87 men (42%), with mean age of 63 years and average diabetes duration of 13 years. The mean annual cost was US$ 1,844 per patient, out of which US$ 1,012 corresponded to direct costs (55%) and US$ 831 to indirect costs (45%). From the direct medical costs, medications accounted for the greatest proportion (42%), followed by reactive strips (27%), hospitalizations and procedures (14%), laboratory tests and image examinations (7%), as well as medical consultations (4%). Non-medical costs (transportation) corresponded to 7% of the total direct costs. Besides, the results indicated that men have better quality of life than women. CONCLUSION: This study demonstrated a high T2DM cost in Brazil, considering the governmental per capita expenses in health care, which accounted for US$ 466 in 2010 (World Health Statistics 2013 96-104 2013). Taking into account the high prevalence of the disease (IDF Diabetes Atlas. 5th edition. 29-48 2012), this survey recommends the enforcement of policies for the prevention of diabetes and its complications, and urges for better allocation of healthcare resources.
format Online
Article
Text
id pubmed-4232724
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42327242014-11-16 The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil Borges, Natalie Botelho Ferraz, Marcos Bosi Chacra, Antonio Roberto Diabetol Metab Syndr Research BACKGROUND: The worldwide increase of diabetes, a long duration, slow progression disease, impacts health care costs. The aim of this study was to estimate, from the society’s perspective, the annual cost per patient with Type 2 Diabetes (T2DM) at a specialized, outpatient center in the city of São Paulo, capital of São Paulo state, Brazil. METHODS: Data from 209 patients were collected during the years 2009 and 2010 in a São Paulo diabetes care center which is part of the tertiary sector of SUS, Brazil’s National Health Care System. Data were collected by means of interviews and reviews of medical charts, and the quality of life was appraised using the SF36-v2 questionnaire. Direct medical costs were divided in five categories: 1) medication; 2) laboratory tests; 3) hospitalizations and procedures; 4) reactive strips for capillary blood glucose monitoring; and 5) medical consultations. Direct non-medical costs referred to transportation of patient and companion for treatment. Indirect costs included early retirements, sick leave and absenteeism in the workplace. Statistical analysis of the data was performed by the SPSS software, version 17.0. RESULTS: Our sample comprised 122 women (58%) and 87 men (42%), with mean age of 63 years and average diabetes duration of 13 years. The mean annual cost was US$ 1,844 per patient, out of which US$ 1,012 corresponded to direct costs (55%) and US$ 831 to indirect costs (45%). From the direct medical costs, medications accounted for the greatest proportion (42%), followed by reactive strips (27%), hospitalizations and procedures (14%), laboratory tests and image examinations (7%), as well as medical consultations (4%). Non-medical costs (transportation) corresponded to 7% of the total direct costs. Besides, the results indicated that men have better quality of life than women. CONCLUSION: This study demonstrated a high T2DM cost in Brazil, considering the governmental per capita expenses in health care, which accounted for US$ 466 in 2010 (World Health Statistics 2013 96-104 2013). Taking into account the high prevalence of the disease (IDF Diabetes Atlas. 5th edition. 29-48 2012), this survey recommends the enforcement of policies for the prevention of diabetes and its complications, and urges for better allocation of healthcare resources. BioMed Central 2014-11-08 /pmc/articles/PMC4232724/ /pubmed/25400703 http://dx.doi.org/10.1186/1758-5996-6-122 Text en © Borges et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Borges, Natalie Botelho
Ferraz, Marcos Bosi
Chacra, Antonio Roberto
The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil
title The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil
title_full The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil
title_fullStr The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil
title_full_unstemmed The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil
title_short The cost of type 2 diabetes in Brazil: evaluation of a diabetes care center in the city of São Paulo, Brazil
title_sort cost of type 2 diabetes in brazil: evaluation of a diabetes care center in the city of são paulo, brazil
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232724/
https://www.ncbi.nlm.nih.gov/pubmed/25400703
http://dx.doi.org/10.1186/1758-5996-6-122
work_keys_str_mv AT borgesnataliebotelho thecostoftype2diabetesinbrazilevaluationofadiabetescarecenterinthecityofsaopaulobrazil
AT ferrazmarcosbosi thecostoftype2diabetesinbrazilevaluationofadiabetescarecenterinthecityofsaopaulobrazil
AT chacraantonioroberto thecostoftype2diabetesinbrazilevaluationofadiabetescarecenterinthecityofsaopaulobrazil
AT borgesnataliebotelho costoftype2diabetesinbrazilevaluationofadiabetescarecenterinthecityofsaopaulobrazil
AT ferrazmarcosbosi costoftype2diabetesinbrazilevaluationofadiabetescarecenterinthecityofsaopaulobrazil
AT chacraantonioroberto costoftype2diabetesinbrazilevaluationofadiabetescarecenterinthecityofsaopaulobrazil